arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Compugen Ltd.

CGEN Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$2.30
▲ +0.9% Today
as of Aug 5, 16:47 ET
Last 30 days +5.56% Jun 29 → Aug 05
$2.10 $2.21 $2.31 $2.41 $2.52 Jun 29 Jul 07 Jul 14 Jul 22 Jul 29 Aug 05
Open
$2.19
High
$2.20
Low
$2.07
Volume
$242,430
Avg Vol
$378,758
Mkt Cap
$221M
P/E (TTM)
—
Beta
—
52w High
$3.24
52w Low
$1.30
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 13 items

Aug 6 · 01:01 GuruFocus.com
Compugen Ltd (CGEN) (Q2 2026) Earnings Call Highlights: Advancing COM701 with Strong Cash ...
Aug 4 · 12:30 Moby
Compugen Ltd. Q2 2026 Earnings Call Summary
Aug 3 · 14:04 MarketBeat
Compugen Q2 Earnings Call Highlights
▸ Show all 13 press releases & news Free account →

Overview

52-week range
$1.30
$3.24
52% of range
Avg surprise (last 3)
-20.6%
Avg reaction (last 2)
+2.0%
50% positive
Latest IV / EM
122%
EM ±21.0% · $3 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.58$-0.32$-0.07$0.19$0.44 Actual $-0.08Est $-0.06Actual $-0.08Est $-0.07Actual $-0.08Est $-0.07 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 18, 2026Mar/2026 $-0.08 $-0.07 -14.3% 0.0% +4.0% earnings
Wed Aug 6, 2025Jun/2025 $-0.08 $-0.07 -14.3% — — earnings
Mon May 19, 2025Mar/2025 $-0.08 $-0.06 -33.3% — 0.0% earnings

Implied volatility — last 90 days

54%341%628%915%1203% Jun 08 — IV 371% · EM ±49.0%Jun 09 — IV 380% · EM ±47.6%Jun 10 — IV 475% · EM ±56.1%Jun 11 — IV 532% · EM ±58.8%Jun 12 — IV 527% · EM ±53.9%Jun 15 — IV 650% · EM ±47.0%Jun 16 — IV 792% · EM ±46.8%Jun 17 — IV 1203% · EM ±50.3%Jun 19 — IV 236% · EM ±52.2%Jul 09 — IV 86% · EM ±10.1%Jul 10 — IV 95% · EM ±10.5%Jul 21 — IV 78% · EM ±18.1%Jul 22 — IV 54% · EM ±12.4%Jul 31 — IV 56% · EM ±10.6%Aug 03 — IV 59% · EM ±10.5%Aug 04 — IV 122% · EM ±21.0%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,164.75-0.4%
JNJ
Johnson & Johnson
$624.1B $258.23+0.2%
ABBV
AbbVie Inc.
$454.8B $246.35+0.1%
MRK
Merck & Company, Inc.
$321.6B $129.20+0.7%
PM
Philip Morris International Inc
$299.3B $188.93-0.0%
NVS
Novartis AG
$297.9B $154.440.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in